AustraliaJohnson & Johnson (J&J) has agreed to pay up to $7.9 billion to resolve approximately 76,000 lawsuits alleging its talc-based baby powder products caused ovarian cancer. The settlement includes both federal and state court cases and requires approval from 95% of claimants. J&J's vice president called the claims 'meritless,' while plaintiffs' attorneys described the deal as a fair resolution after a decade-long legal battle. Payments will occur in installments between 2027 and 2028, with the final amount potentially exceeding $7 billion depending on participation rates. In Australia, a class-action lawsuit against J&J continues, with plans for a case management conference in late 2026.
Bias read (Center): The article presents a balanced account of the settlement, quoting both J&J executives and plaintiff attorneys. It avoids taking sides on the merits of the claims and focuses on factual reporting rather than advocacy. While the issue of product liability is politically sensitive, the framing remains
